The anti-Warburg ruthenium compound BOLD-100 targets the cellular lipid metabolism and impacts on histone acetylation
- Baier, D. (Contributor)
- Theresa Mendrina (Contributor)
- B. Schoenhacker-Alte (Contributor)
- Mate Rusz (Contributor)
- H. Herrmann (Contributor)
- Christine Pirker (Contributor)
- Thomas Mohr (Contributor)
- Meier-Menches, S. M. (Contributor)
- Benedikt Regner (Contributor)
- Gerhard Zeitler (Contributor)
- Karin Nowikovsky (Contributor)
- Zanghellini, J. (Contributor)
- Köllensperger, G. (Contributor)
- Petra Heffeter (Contributor)
- Keppler, B. (Contributor)
- Walter Berger (Contributor)
Activity: Talks and presentations › Poster presentation › Science to Science